These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15194047)

  • 1. A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy.
    Chia MC; Shi W; Li JH; Sanchez O; Strathdee CA; Huang D; Busson P; Klamut HJ; Liu FF
    Mol Ther; 2004 Jun; 9(6):804-17. PubMed ID: 15194047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted gene therapy for nasopharyngeal carcinoma.
    Li JH; Chia M; Shi W; Ngo D; Strathdee CA; Huang D; Klamut H; Liu FF
    Cancer Res; 2002 Jan; 62(1):171-8. PubMed ID: 11782375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy.
    Mocanu JD; Yip KW; Alajez NM; Shi W; Li JH; Lunt SJ; Moriyama EH; Wilson BC; Milosevic M; Lo KW; van Rooijen N; Busson P; Bastianutto C; Liu FF
    Mol Ther; 2007 May; 15(5):921-9. PubMed ID: 17356543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
    Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
    J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential efficacy of p16 gene therapy for EBV-positive nasopharyngeal carcinoma.
    Li AA; Ng E; Shi W; Lee A; Chia M; Liu TJ; Huang D; O'Sullivan B; Gullane P; Liu FF
    Int J Cancer; 2004 Jun; 110(3):452-8. PubMed ID: 15095314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential utility of BimS as a novel apoptotic therapeutic molecule.
    Yip KW; Li A; Li JH; Shi W; Chia MC; Rashid SA; Mocanu JD; Louie AV; Sanchez O; Huang D; Busson P; Yeh WC; Gilbert R; O'sullivan B; Gullane P; Liu FF
    Mol Ther; 2004 Sep; 10(3):533-44. PubMed ID: 15336653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
    Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of targeted FasL in nasopharyngeal carcinoma.
    Li JH; Shi W; Chia M; Sanchez-Sweatman O; Siatskas C; Huang D; Busson P; Klamut H; Yeh WC; Richardson C; O'Sullivan B; Gullane P; Neligan P; Medin J; Liu FF
    Mol Ther; 2003 Dec; 8(6):964-73. PubMed ID: 14664799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the Modulation of Adenoviral Kinetics and Biodistribution for Cancer Gene Therapy.
    Mocanu JD; Yip KW; Alajez NM; Shi W; Li JH; Lunt SJ; Moriyama EH; Wilson BC; Milosevic M; Lo KW; van Rooijen NV; Busson P; Bastianutto C; Liu FF
    Mol Ther; 2007 May; 15(5):921-929. PubMed ID: 28182894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.
    Zuo Y; Wu J; Xu Z; Yang S; Yan H; Tan L; Meng X; Ying X; Liu R; Kang T; Huang W
    PLoS One; 2011 May; 6(5):e19407. PubMed ID: 21573215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
    Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
    Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
    Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
    Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
    Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS
    Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L; Li JH; Donovan J; Huang D; Liu FF
    Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase-dependent oncolytic adenovirus for cancer treatment.
    Huang TG; Savontaus MJ; Shinozaki K; Sauter BV; Woo SL
    Gene Ther; 2003 Aug; 10(15):1241-7. PubMed ID: 12858189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma.
    Lee AW; Li JH; Shi W; Li A; Ng E; Liu TJ; Klamut HJ; Liu FF
    Mol Cancer Ther; 2003 Oct; 2(10):961-9. PubMed ID: 14578461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.